针治疗严重肌痛症患者 - 一个随机临床试验
Amanda A Herrmann1,2, Ella A Chrenka1,2, Lap Pui Chung1,3
1HealthPartners Institute, Bloomington, MN, USA.
Global advances in integrative medicine and health
|September 2, 2025
概括
针是一种可行且安全的治疗方法, 这项试点研究表明可能改善症状,为更大规模的疗效试验铺平了道路.
科学领域:
- 神经学
- 综合医学
- 自身免疫性疾病
背景情况:
- 肌痛性硬化 (MG) 是一种罕见的自身免疫性疾病,导致显著的肌肉衰弱.
- 目前用于MG的药物治疗可能与长期使用相关的安全问题.
- 针对治疗MG症状和可能增加药物的疗效具有前景.
研究的目的:
- 评估MG患者针试验的可行性和安全性.
- 评估患者坚持并确定参与MG针RCT的潜在障碍.
主要方法:
- 在24名MG参与者中进行了一项随机对照试验.
- 参与者在12周内被随机分配到即时或延迟针治疗组.
- 使用标准化的21点针方案,根据传统中医诊断进行个性化补充.
主要成果:
- 这项研究表明,针治疗对MG患者来说是可行的和安全的.
- 在24名参与者中,有17人完成了全部针治疗方案.
- 大多数不良反应 (17) 是轻微的局部反应,表明安全性很好.
结论:
- 针治疗是可行的,对于被诊断为肌痛性硬化症的人来说是安全的.
- 在针治疗后,参与者报告了MG症状的自我改善.
- 未来的研究将集中在严格的疗效RCT上,以确定针对MG的临床意义.
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K
01:15Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K